Furthermore, their anti-obesity effect is carried out by inhibiting the transcriptional activities of PPARγ, suppressing adipocyte differentiation, proliferation, and lipogenesis, and promoting adipocyte apoptosis, lipolysis, and fatty acid oxidation [68,69,70]. Here, PPARG is linked to obesity due to melanocortin 4 receptor deficiency.